ADVANCED SOLID TUMORS CANCER
Clinical trials for ADVANCED SOLID TUMORS CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMORS CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMORS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ORB-021 enters human testing for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests whether the investigational drug ORB-021 is safe and tolerable in 36 adults with advanced solid tumors that have not responded to standard treatments. Researchers will also find the best dose for future studies. Participants will go through screening,…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
New hope for hard-to-treat cancers: targeted combo therapy enters trials
Disease control Recruiting nowThis study tests a new drug (GFH375) combined with either another targeted therapy (cetuximab) or chemotherapy in people with advanced solid tumors that have a specific KRAS G12D mutation. The goal is to see if these combinations are safe and can shrink tumors. About 126 adults w…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new daily pill, NDI-219216, in 134 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, side effects, and whether the drug can shrink tumors. Participants take the pill daily, visit th…
Matched conditions: ADVANCED SOLID TUMORS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Nimbus Wadjet, Inc. • Aim: Disease control
Last updated May 01, 2026 15:59 UTC